Galderma successfully launches its IPO on SIX Swiss Exchange

Niederer Kraft Frey advised a syndicate of 15 banks, led by Goldman Sachs, Morgan Stanley and UBS as joint global coordinators, in connection with the initial public offering of Galderma Group AG that launched on 13 March 2024.

MANDI invests in Cultivated Biosciences

Niederer Kraft Frey acted as counsel to Mandi Ventures (MANDI) on its investment in Cultivated Biosciences SA.

abrantix announces the joint venture PaytestLab with B2 Payment Solutions

Niederer Kraft Frey advised abrantix AG on its joint venture with B2 Payment Solutions Inc.

Groupe Factoria acquires PRINTHOF GmbH

Niederer Kraft Frey advised Groupe Factoria on the acquisition of PRINTHOF GmbH.

Calibre Scientific acquires Ruwag

Niederer Kraft Frey advised Calibre Scientific, Inc., (Calibre Scientific) on the acquisition of Ruwag Handels AG.

Springer Nature secures EUR 2.5bn financing

Niederer Kraft Frey advised the banking consortium led by Commerzbank Aktiengesellschaft, ING Bank, a branch of ING-DiBa AG,

Bertrand Piccard unveils Climate Impulse, a new flagship for climate action

Niederer Kraft Frey advised Bertrand Piccard and Climate Impulse on the project set-up and the partnership agreement with Syensqo.

Evolva Holding SA sells its operations to Lallemand Inc.

Niederer Kraft Frey advised Evolva Holding SA on the sale of its wholly-owned operating subsidiary Evolva AG to Danstar Ferment AG, a Swiss affiliate of Lallemand Inc.

MVM Partners closes USD 30m investment in icotec ag

Niederer Kraft Frey advised MVM Partners on its investment in icotec ag.

Demathieu Bard acquires Steiner Construction SA

Niederer Kraft Frey advised Demathieu Bard on the acquisition of Steiner Construction SA.